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Objective: To evaluate the functional capacity of granulocytes and monocytes from pregnant and nonpregnant
women in relation to group B streptococcus (GBS) colonization status.
Methods: Engulfmentof fluorescentGBS by peripheral blood phagocytes from GBS-colonized and noncolonized
women was measured by flow cytometry. Intracellular superoxiode generated in response to GBS challenge to
monocytes and granulocytes enriched from peripheral blood of these women was also measured by flow
cytometry, and extracellular superoxide was determined by colorimetric assay.
Results: Monocytes and granulocytes from pregnant, GBS-colonized women engulfed significantly greater
numbers of GBS than phagocytes from pregnant,noncolonized women. No difference in intracellular superoxide
production was detected between any of the groups of women; however, monocytes from pregnant, colonized
women released significantly more superoxide into the extracellular milieu than did granulocytes from the same
women. No differences in extracellular release of superoxide were observed among noncolonized women
whether they were pregnant or not.
Conclusions: Monocytes from pregnant,colonized women engulfmore GBS and release more of the superoxide
into the extracellular environment, where it is unlikely to be an effective defense mechanism against intracellular
bacteria. This suggests that components of the innate immune system that should serve in a protective role may
function suboptimally, thereby contributing to the colonization process by GBS.
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Over the past 30 years group B streptococcus
(GBS) has gained prominence as the primary
etiologicagentofsepsis, bacteremia andmeningitis
in the neonatal period. Administration of intra-
partum antibiotics to women identified at risk for
transmitting GBS can be effective in prevention of
transmission and early-onset disease1, but it fails
to address the underlying problem of maternal
colonization. Despite estimates that between 15
and 35% of women are asymptomatically colo-
nized with GBS2, little is known as to why GBS
can evade the normal immune response in some
women (colonized) and not in others
(noncolonized).
Phagocytic cells, particularly monocytes and
granulocytes, are key mediators of innate
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Clinical study 125immunity to microorganisms, providing an early,
rapid response to a potential pathogen while the
subsequentantigen-specific response is being initi-
ated. Phagocytosis of an organism stimulates pro-
duction of microbicidal reactive oxygen species,
including superoxide radicals and hydrogen per-
oxide. Microbial degradation products generated
from the combined effects of the respiratory burst
and cytolytic enzymes are then processed and
presented to induce either a T cell- or an
antibody-mediated response. Alterations of these
early steps in defense can lead to ineffective clear-
ance of the microorganism. While extreme
examples of these defects, such as leukocyte adhe-
sion deficiencies3 or respiratory burst defects
(chronic granulomatous disease)4, result in severe,
chronicbacterialandfungalinfections,moresubtle
changes due to the uniquephysiologic adaptations
of pregnancy may be involved in the infectious
conditions that are particular threats to mothers
and their newborns.
To evaluate the role that alterations in early
innate immune responses to GBS may play in
supporting the colonization process, the phago-
cytic and respiratory burst capacities of GBS-
colonized and -noncolonized women were
compared. Because GBS colonization is primarily
an obstetric concern and the hormonal changes of
pregnancy influence immunologic functioning,
comparisons were also made between pregnant
and nonpregnantwomen irrespective of coloniza-
tion status.
In this study we show that while pregnant
women display an increased engulfment of GBS,
superoxide release from the phagocytic cells may
be increased, providing a possible explanation for
colonization and modified adaptive immune
response in pregnancy.
SUBJECTS AND METHODS
Study population
The populations studied consisted of pregnantand
nonpregnant women recruited from Marshall
University School of Medicine and its associated
obstetric clinics. All patients were at least 18 years
of age, had no other known active infections
or immunodeficiency, and were not taking
antibiotics in the previous 6 weeks. The study was
approved by the Marshall University School of
Medicine Institutional Review Board, and each
woman gave informed consent prior to partici-
pation. Peripheral blood from each participant
was drawn from the antecubital vein into EDTA
Vacutainer tubes (Becton Dickinson, Franklin
Lakes, NJ). Amies clear StarSwabs (Starplex
Scientific, Ontario, Canada) were used to collect
specimens for determination of GBS colonization
status. Swabs of the lower third of the vagina
from pregnant patients were sent to the Cabell
Huntington Hospital laboratory as part of routine
obstetric screening. Self-collected swabs from the
nonpregnant patients were taken to the research
laboratory. All swabs were incubated in Lim broth
for 12 h at 37°C in 5% CO2. Aliquots of the Lim
broth culture were streaked onto tryptic soy agar
with 5% sheep blood, and incubated overnight at
37°C in 5% CO2. Presumptive identification of
GBS was based on colony morphology, hippurate
catalysis andCAMPtest(research laboratoryonly).
ColonieswereconfirmedasgroupBstreptococcus
by latex agglutination (Meritec Strep Group B
Beta-hemolytic Streptococcus grouping set;
Meridian Diagnostics, Inc., Cincinnati, OH) by
both laboratories.
Based on pregnancy status and the results from
the vaginal swab culturesthe women were placed
into four groups: pregnant, GBS-colonized
(n = 9 for phagocytic assays; n = 5 for superoxide
assays); pregnant,noncolonized (n = 8 for phago-
cytic assays; n = 5 for superoxide assays); non-
pregnant, GBS-colonized (n = 3 for all assays);
and nonpregnant, noncolonized (n = 3 for all
assays). For thepregnant,GBS-colonized women
the mean age was 26.5 years, gravidity ranged
from 1 to 7 and parity ranged from 0 to 4. For the
pregnant, noncolonized women the mean age
was 23.1 years, gravidity ranged from 1 to 6 and
parity ranged from 0 to 2. For the nonpregnant,
GBS-colonized women the mean age was 38.7
yearsandgravidity andparitywereboth0.Forthe
nonpregnant, noncolonized women the mean
age was 30.3 years and gravidity and parity were
both 0. All women were Caucasian with the
exception ofonepregnant,noncolonizedwoman
whowasofAmerican Indianheritage.Allwomen
were healthy volunteers with medical insurance,
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Bacterial preparation
Group B streptococciisolated from asymptomatic,
colonized women during routine gynecologic
exams were assigned the designations 2118 and
2407, corresponding to randomly assigned patient
identification numbers. GBS 2118 and 2407 were
serotypedastypeVandtypeIII,respectively, using
a hemolytic streptococcus group B typing sera kit
(AccurateChemical& ScientificCorp.,Westbury,
NY). GBS 2118 was used for the phagocytic
engulfment assays owing to poor fluorescence
labeling of type III isolates, such as GBS 2407 used
in the superoxide assays.
For the phagocytic engulfment assays, GBS
2118 was labeled by incubation with fluorescein
isothiocyanate (FITC) 1 hydrochloride (Research
Organincs, Cleveland, OH) at 50 mg/ml in
Todd–Hewitt broth for 16 h at 37°C in 5% CO2.
The cultures were centrifuged, washed twice with
phosphate-buffered saline (PBS) and heat-killed at
60°C for 45 min prior to resuspension to a final
concentrationof108bacteria/ml.Afterconfirming
staining via flow cytometry (FACScan, Becton
Dickinson, San Jose, CA) the FITC–GBS were
aliquoted and stored at 70°C until needed.
Forthesuperoxideassays, GBS2407wasinocu-
lated from frozen stocks and cultured in
Todd–Hewitt broth at 37°C in 5% CO2 until an
optical density at 600 nm (OD600) of 0.4 was
reached (approximately 4 h).
Phagocytic engulfment
Plasma was removed from 100 ml of whole blood.
The cell pellets were washed twice in Dulbecco’s
phosphate-buffered saline (DPBS) and resus-
pended in 100 ml heat-inactivated, pooled,human
typeABserum(Sigma, StLouis,MO).Thepooled
human type AB serum failed to agglutinate GBS
2118in a slide agglutinationtest. FITC–GBS 2118
was sonicated briefly to create a single-cell suspen-
sion prior to adding 10 ml to each tube of resus-
pended leukocytes. After incubation at 37°C on a
rotary shaker for the appropriate length of time,
cytochalasin D (Sigma, St Louis, MO) was added
to each tube (5 mmol/l final concentration). The
contents of each tube were diluted with ice-cold
DPBS, centrifuged and washed twice with
cold DPBS. Erythrocytes were lysed using
ImmunoLyse (Coulter, Miami, FL) according to
the manufacturer’s instructions. The leukocyte
pellet was washed twice with DPBS and the cells
were stained for CD14 (phycoerythrin-labeled
clone TUK1; Caltag Laboratories, Burlingame,
CA) to allow for differentiation of leukocyte
populations using flow cytometry. Stained cells
were fixed in 4% paraformaldehyde and analyzed
byflowcytometry.Side lightscatterpropertiesand
CD14 staining were used to discriminate between
monocytes and granulocytes. A minimum of
5000 events wascollectedforeachpopulation,and
analyzed for the percentage of cells having
engulfed FITC–GBS and for mean fluorescence
intensity using CellQuest Software (Becton
Dickinson).
Superoxide assays
Enriched populations of monocytes and granulo-
cytes were used for measurements of superoxide
generated subsequentto engulfmentof GBS 2407.
Monocytes were enriched from whole peripheral
blood by density gradient centrifugation using
Ficoll Paque Plus (Amersham Pharmacia Biotech,
Piscataway, NJ), followed by negative selection
using the StemSep human monocyte enrichment
system (Stem Cell Technologies, Vancouver, BC
Canada). Granulocytes were enriched from the
erythrocyte–granulocyte pellet from the density
gradient centrifugation by dextran sedimentation
(500 000 average molecular weight; Sigma),
followed by hypotonic saline erythrocyte lysis.
Viability was assessed bytrypan bluestaining, and a
minimum viability of 90% was required for use in
any assay. Purity of the enriched monocyte popu-
lations was demonstrated using flow cytometry.
PuremonocyteswerepositiveforCD14andnega-
tive for CD3 (clone UCHT1; BD PharMingen,
San Diego, CA) and CD19 (clone HIB19; BD
PharMingen). Purity of the enriched granulocyte
populations was demonstrated using forward and
side light scatter properties via flow cytometry.
One hundred-microliter aliquots of enriched
monocytes or granulocytes (1 ´ 106 cells/ml) in
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(10 mmol/l final concentration; Polysciences Inc.,
Warrington, PA) for 15 min at 37°C. The cells
were stimulated by the addition of either phorbol
12-myristate 13-acetate (PMA) at a 200 ng/ml
final concentration or 10 ml of log-phase GBS
2407. The fluorescence level was immediately
determined by flow cytometry and was used as the
zero time point. The granulocytes and monocytes
were incubated for 20 min and 45 min, respec-
tively, at 37°C with thestimulators beforethe final
fluorescence reading was taken. A minimum of
5000 events were collected for each population,
and analyzed for the percentage of cells with
an increase in fluorescence over time after
stimulation.
In order to measure superoxide released from
themonocytesandgranulocytes,100 mlaliquotsof
cells (1 ´ 106/ml) in PBS-gel were incubated for
45 min at 37°C in 5% CO2with 25 ml cytochrome
c (2.7 mg/ml; from horse heart), in the presence
(25 ml) or absence of superoxide dismutase
(1 mg/ml; SOD; from bovine erythrocytes), and
with either 200 ng/ml PMA or 10 ml of log-
phaseGBS 2407.Monocyte-andgranulocyte-free
tubes were prepared as controls. After incubation
the tubes were centrifuged and the supernatants
were transferred to a 96-well plate. The
absorbance at 550 nm was read and used to
calculate the nanomoles of superoxide released
according to the following formula: (experimental
– matched cell-free control) – (experimental with
SOD – matched cell-free control)/47.4.
Statistical analysis
Statistical analyses were performed using the
SigmaStat softwarepackage(Jandel ScientificSoft-
ware, San Rafael, CA). Student’s t-test was used
for comparisons of pregnant versus nonpregnant
women and colonized versus noncolonized
women.A value of p < 0.05 was considered statis-
tically significant. The t-test sample size program
(a = 0.05 and power = 0.8) was used to estimate
thenumberofindividuals neededto providestatis-
tical significance when p > 0.05.
RESULTS
Phagocytic engulfment
The percentages of monocytes and granulocytes
having engulfed FITC–GBS 2118 were measured
by flow cytometry and compared between
GBS-colonized and -noncolonized women. No
significant differences were observed between
these groups of women regardless of pregnancy
status (Table 1).
Although no differences in the percentages of
phagocytes having engulfed FITC–GBS 2118
were observed, measurements of mean fluores-
cence intensity revealed a significant difference in
the relative number of FITC–GBS 2118 taken up
by phagocytes from pregnant, colonized women
when compared with pregnant, noncolonized
women. Granulocytes from pregnant, colonized
women engulfed approximately twicethenumber
of FITC–GBS 2118 after 20 and 45 min compared
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% Phagocytes containing GBS
Pregnancy status Colonization status Cell type 20 min 45 min
Pregnant
Nonpregnant
Colonized
(n = 9)
Noncolonized
(n = 8)
Colonized
(n = 3)
Noncolonized
(n = 3)
Monocytes
Granulocytes
Monocytes
Granulocytes
Monocytes
Granulocytes
Monocytes
Granulocytes
55.9 ± 7.8
58.6 ± 18.6
34.7 ± 7.8
29.4 ± 11.4
48.4 ± 14.9
52.3 ± 21.2
37.4 ± 15.5
25.6 ± 9.8
69.1 ± 12.8
79.1 ± 14.3
42.0 ± 19.2
40.7 ± 18.7
55.5 ± 14.1
67.3 ± 19.4
44.1 ± 11.6
37.1 ± 30.0
Table 1 Percentages (mean ± SD) of phagocytes having engulfed fluorescein isothiocyanate–group B streptococcus
(FITC–GBS) 2118 over timewith those from pregnant, noncolonized women
(Figure 1a). Monocytes from pregnant, colo-
nized women engulfed more than five times the
number of FITC–GBS 2118 after 45 min com-
pared with those from pregnant, noncolonized
women (Figure 1a). These differences were not
observed for nonpregnant women (Figure 1b) or
in parallel experiments substituting Staphylococcus
aureus (ATCC 25923) for GBS 2118 (data not
shown).
Superoxide assays
Preliminaryexperimentswere conductedtodeter-
mine the time and PMA concentration required
for optimal superoxide production. The concen-
trations and time points used in both superoxide
assays reflected maximal PMA as well as GBS
stimulation.
A comparison of the percentages of enriched
monocytesandgranulocytesproducingintracellular
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Figure 1 Mean fluorescence intensity of engulfed
fluorescein isothiocyanate–group B streptococcus
(FITC–GBS) 2118 over time. Monocytes and granulo-
cytes from colonized (black bars) and noncolonized
(white bars), pregnant (a) and nonpregnant (b) women
were incubated with FITC–GBS 2118 for 20 or 45 min.
Mean fluorescence intensity was measured using flow
cytometry. Significant differences between colonized
and noncolonized women are denoted by asterisks
(p < 0.05 using Student’s t-test). Pregnant, colonized:
n = 9; pregnant, noncolonized: n = 8; nonpregnant,
colonized: n = 3; nonpregnant, noncolonized; n = 3
Figure 2 Generation of intracellular superoxide after
stimulation with phorbol 12-myristate 13-acetate (PMA)
or group B streptococcus (GBS) 2407. Enriched popula-
tions of monocytes and granulocytes from colonized
(black bars) and noncolonized (white bars), pregnant (a)
and nonpregnant (b) women were loaded with
hydroethidine prior to incubation at 37°C with PMA
(200 ng/ml) or log-phase GBS 2407. The increase in fluo-
rescence due to superoxide oxidation of hydroethidine
to ethidium bromide was measured using flow
cytometry at 20 min (granulocytes) and 45 min
(monocytes) after stimulation. No significant differences
among any of the groups were observed. Pregnant,colo-
nized and noncolonized: n = 5; nonpregnant, non-
colonized: n = 3superoxide in response to challenge with log-phase
GBS 2407 failed to show significant differences
between GBS-colonized and noncolonized
women, regardless of pregnancy status (Figure 2).
Not all superoxide generated intracellularly
remains as such.Extracellular release of superoxide
by enriched monocytes and granulocytes in
response to challenge with log-phase GBS 2407
was measured spectrophotometrically after
45 min. No significant differences between
colonized and noncolonized women were
detected. However, monocytes from pregnant,
colonized women released a significantly greater
amount of superoxide (0.78 ± 0.8 nmol) into the
extracellular environment than did the granulo-
cytes from these same women (0.0 ± 0.0 nmol)
(Figure 3a). This difference was not observed for
noncolonized women regardless of pregnancy
status (Figure 3a and b). Parallel experiments with
S. aureus 25923 again demonstrated the specificity
of these differences in relation to GBS (data
not shown).
DISCUSSION
Despite recent efforts to devise more accurate and
cost-effective methods for identifying and treating
pregnant women at risk of transmitting GBS to
their newborns, much remains to be learned con-
cerning basic immunity to GBS. Perhaps the most
important issue in this area is why certain women
become colonized with GBS while others effec-
tively eliminate it. We have proposed that the
way in which the innate immune system in GBS-
colonized women responds to GBS differs from
thatin noncolonizedwomen,andthatthese differ-
ences may assist in the initiation of colonization.
To test this proposal we compared the abilities of
phagocytes from colonized and noncolonized
women to engulf GBS and generate the micro-
bicidal superoxide radical following engulfment.
Possible contributions owing to pregnancy were
also evaluated by comparing responses from
pregnant and nonpregnant women.
While no differences in the number of phago-
cytes having engulfed GBS were observed for any
of the groups of women, the bacterial load in
phagocytes from pregnant, colonized women was
significantly greater than for pregnant, non-
colonized women. This effect was probably not
duetoopsonicantibody,since heterologousserum
that failed to agglutinate GBS was used in these
assays. Both granulocytes and monocytes from
pregnant, GBS-colonized women engulfed
greater numbers of GBS. Although overall
enhancedphagocyticability is frequently observed
during pregnancy5–7, the greater than five-fold
increase in engulfment by monocytes and the
two-fold increase in engulfment by granulocytes
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Figure 3 Release of superoxide into the extracellular
milieu following stimulation with phorbol 12-myristate
13-acetate (PMA) or group B streptococcus (GBS) 2407.
Enriched populations of monocytes and granulocytes
from colonized (black bars) and noncolonized (white
bars), pregnant (a) and nonpregnant (b) women were
stimulated with PMA (200 ng/ml) or log-phase GBS 2407
for 45 min at 37°C. The nanomoles of superoxide
released were calculated from changes in absorbance at
550 nm. Significant differences between monocytes and
granulocytes from pregnant, colonized women are
denoted by asterisks (p < 0.05 using Student’s t-test).
Pregnant, colonized and noncolonized: n = 5; non-
pregnant, colonized and noncolonized: n = 3from pregnant, GBS-colonized women appears to
be specific to GBS, as these differences were not
observed in parallel experiments with S. aureus.
Following phagocytic engulfment of GBS,
superoxide is generated within the phagocyte by
phagosome-associated, reduced nicotinamide
adenine dinucleotide phosphate (NADPH)
oxidase. Not surprisingly, differences with regard
to the percentage of phagocytes producing super-
oxide were not seen, but there was a difference
with respect to pregnant, GBS-colonized women
in the amount of superoxide released from
monocytes versus granulocytes. The release of
superoxide into the extracellular environment
was greater from monocytes in pregnant, GBS-
colonized women. Granulocytes from these
women failed to release any superoxide
extracellularly.
Themechanismunderlyingtherelease ofsuper-
oxide generated within the phagosome into the
extracellular environmentisunclear.Twopossible
explanations can be envisioned, one phago-
cyte-associated and one GBS-associated. The
respiratory burst associated with phagocytic
engulfment is activated following specific
microbe–phagocyte receptor interactions. If the
respiratory burst is activated through these inter-
actions prior to complete closure of the phago-
some, superoxide could leak into the extracellular
environment. Alternatively, factors produced by
GBS may break down the phagocyte membrane
integrity, leading to leakage of superoxide outside
the cell. Studies have shown that GBS can cross
various types of eukaryotic cell membranes,
includingthosefromhumanchorioncells8,human
umbilical vein endothelial cells9, human lung epi-
thelial cells10 and human monocytes11. Using GBS
serotype III strains producing different levels of
b-hemolytic activity9,10, or using agents that
inhibit GBS b-hemolysin11, it has been demon-
strated that the b-hemolysin produced by GBS
disrupts cellular membranes, alters membrane per-
meability and causes the release of lactate
dehydrogenase. Based on the findings of these
studies it can be argued that the b-hemolysin pro-
ducedbyGBS 2407,theserotypeIIIisolateusedin
our superoxide assays, may damage the plasma
and/orphagosomemembranes, leadingtoarelease
of superoxide into the extracellular environment.
Both of these possible mechanisms for the release
of superoxideare subjectsfor futureinvestigations,
perhaps by using strains with a deletion of the
b-hemolysin gene.
Althougha number of studies have investigated
the interactions between GBS and phagocytes,
only one employs flow cytometry to measure
phagocytic engulfment and superoxide pro-
duction12. In that study the authors report that
phagocytosis of GBS and superoxide production
after ingestion are greater for neutrophils than
for monocytes, but it does not evaluate the effect
of pregnancy, which may explain the differ-
ences from our study. In addition to differences
in study populations, McCloskey and Salo use
GBS incubated with antibody and complement to
examine opsonophagocytosis. In contrast, our
study used unopsonized GBS to examine
engulfment.
In that colonizationstatus, as well as pregnancy,
defined our subject populations, we were aware
thatsample collectiontechniqueswouldinevitably
lead to variations in GBS recovery rates. We
elected to allow the physician to determine the
collection procedure. As only lower-vaginal seg-
ment GBS colonization was examined in our
study, GBS carriage may have been modestly
underestimated. However, statistical sample size
evaluation suggested that the addition of more
subjects was unlikely to alter the conclusions of
the study.
The results of our investigations indicated a
unique interaction between GBS and monocytes
frompregnant,GBS-colonizedwomen. GBS may
accumulate in large numbers in monocytes from
colonized,pregnantwomen,whichtend torelease
their superoxide into the extracellular milieu.
Superoxide is most likely to be more potent when
sequestered in an intracellular location; therefore,
these monocytes, which have released their
superoxide, may in effect create an intracellular
niche for GBS. Other recent studies support the
idea that monocytesprovide an intracellular haven
for GBS. Several groups have reported that GBS
can persist intracellularly in murine macrophages
for 24–48 h following infection13,14, as well as in-
activate the protein kinase C pathway, one of
the main signal transduction pathways leading to
macrophage activation14.
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monocytes from pregnant, colonized women
demonstratedhereprovidetheinitialevidencethat
the immune system, which should function in a
protective fashion, may not contribute to the pre-
vention of GBS colonization.These alterations are
by no means the only contributory factors in the
colonization process, but provide a framework for
further dissection of theunderlyingmechanism. In
the process of elucidating the mechanism leading
to GBS colonization, more information on the
immune response to GBS will be generated, and
may provide a clearer path to the design of an
effective GBS vaccine.
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